egtazic acid has been researched along with Granulocytic Leukemia, Chronic in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Boffo, S; Caparrotti, G; Ciarcia, R; d'Angelo, D; Damiano, S; Florio, S; Giordano, A; Montagnaro, S; Morales, F; Pagnini, U; Rizzolio, F; Ruocco, A | 1 |
| Heise, N; Henke, G; Huber, SM; Koka, S; Lang, F; Misovic, M; Palme, D; Rudner, J; Salih, HR | 1 |
| Koide, Y; Miyachi, H; Sekiguchi, S; Shibata, T; Takemura, Y; Tukemura, Y | 1 |
3 other study(ies) available for egtazic acid and Granulocytic Leukemia, Chronic
| Article | Year |
|---|---|
Combined effects of PI3K and SRC kinase inhibitors with imatinib on intracellular calcium levels, autophagy, and apoptosis in CML-PBL cells.
Topics: Apoptosis; Autophagy; Benzamides; Calcium; Calcium Signaling; Cell Line, Tumor; Chromones; Drug Synergism; Egtazic Acid; Humans; Imatinib Mesylate; Inositol Phosphates; Intracellular Space; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Morpholines; Phosphatidylinositol 3-Kinase; Phosphoinositide-3 Kinase Inhibitors; Piperazines; Protein Kinase Inhibitors; Pyrazoles; Pyrimidines; src-Family Kinases; Thapsigargin | 2013 |
Non-selective cation channel-mediated Ca2+-entry and activation of Ca2+/calmodulin-dependent kinase II contribute to G2/M cell cycle arrest and survival of irradiated leukemia cells.
Topics: Calcium; Calcium Channels; Calcium-Calmodulin-Dependent Protein Kinase Type 2; Cell Division; Chelating Agents; Egtazic Acid; Fura-2; G2 Phase; Humans; K562 Cells; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Patch-Clamp Techniques; Protein Kinase Inhibitors; Radiation Tolerance; Radiation, Ionizing; TRPV Cation Channels | 2010 |
Effect of verapamil on the class I major histocompatibility complex antigen expression in K562 chronic myelogenous leukemia cells treated with recombinant human interferon-gamma.
Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Antibodies, Monoclonal; Blotting, Northern; Calcimycin; Calmodulin; Cell Line; Egtazic Acid; Genes, MHC Class I; Genes, myc; Histocompatibility Antigens Class I; Humans; Interferon-gamma; Isoquinolines; Kinetics; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Piperazines; Protein Kinase Inhibitors; Recombinant Proteins; RNA, Neoplasm; Signal Transduction; Sulfonamides; Tumor Necrosis Factor-alpha; Verapamil | 1992 |